Skip to main content

Navigation group

Type at least 3 characters
442 articles

Articles

Original Research

Published on 19 Jan 2023

RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensives

in Translational and Clinical Endocrinology

  • Mykola Khalangot
  • Nadiia Sheichenko
  • Vitaly Gurianov
  • Tamara Zakharchenko
  • Victor Kravchenko
  • Mykola Tronko
RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensives
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1077959
  • 2,069 views
  • 3 citations